Literature DB >> 25594888

Distinct management issues with Crohn's disease of the small intestine.

Steven C M Fong1, Peter M Irving.   

Abstract

PURPOSE OF REVIEW: Small bowel Crohn's disease can present with clinical challenges that are specific to its location. In this review, we address some of the areas that present particular problems in small bowel Crohn's disease. RECENT
FINDINGS: A key issue specific to small bowel Crohn's disease relates to its diagnosis given that access to the small bowel is limited. Radiological advances, particularly in small bowel ultrasonography and MRI, as well as the introduction of capsule endoscopy and balloon enteroscopy are helping to address this. In addition, our ability to differentiate small bowel Crohn's disease from other causes of inflammation, such as tuberculosis, is improving on the basis of better understanding of the features that differentiate these conditions. It is also becoming apparent that jejunal Crohn's disease represents a distinct disease phenotype with potentially worse clinical outcomes. Finally, because it is a rare complication, our understanding of small bowel cancer associated with Crohn's disease remains limited. Recent publications are, however, starting to improve our knowledge of this condition.
SUMMARY: Although small bowel Crohn's disease presents specific management issues not seen in patients with Crohn's disease elsewhere in the gastrointestinal tract, our knowledge of how to manage these is improving.

Entities:  

Mesh:

Year:  2015        PMID: 25594888     DOI: 10.1097/MOG.0000000000000149

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  1 in total

Review 1.  Enteroscopy in children and adults with inflammatory bowel disease.

Authors:  Giovanni Di Nardo; Gianluca Esposito; Chiara Ziparo; Federica Micheli; Luigi Masoni; Maria Pia Villa; Pasquale Parisi; Maria Beatrice Manca; Flavia Baccini; Vito Domenico Corleto
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.